OUR MISSION

To build and evolve the European cannabis space while fervently committing to creating high quality products, innovating and improving lives.

Production

100% Swiss Made

HolyWorld SA. is a leading producer of cannabis derived products in Switzerland and Europe. We are actively involved in helping modernise and innovate in the global cannabis industry.

Founded in January 2018 by dynamic entrepreneurs, Holyworld is now a subsidiary of one of the world’s biggest Cannabis conglomerates, MPXI Corporation. We are in search of excellence and opportunities made possible by an emerging global industry. Consumer experience is at heart of everything we do to ensure MPXI brands reflect the tastes and preferences of current enthusiasts and future customers.

All our flowers are certified, 100% Swiss Made, tobacco and additive free. Our plants are grown on the shores of Lake Geneva with facilities located between the lake the Alps

Production

Bio-Organic Certified

For more than 3 years, Our bio-organic certification guaranties you that our processes of cultivation, harvesting, drying, manicure and curing that best respect the integrity and intrinsic qualities of the plants and that make our products a reference of superior quality unanimously recognized on the market.

All our Swiss-premium quality products are grown, manufactured, and designed to exceed customer satisfaction and serve as the forerunners of the industry.

Real time MPXI stock ticker

Award winning

HolyWorld SA is an international subsidiary of the award-winning cannabis pioneers MPXI. Since 2015, MPXI have been developing leading cannabis operations and innovating award-winning products across both consumer and medical industries in North America. Our managers at MPXI have grown MPX bioceutical from a single Licensed Producer in Canada into one of the largest vertically-integrated, multi-state operators in the US and the world.

MPX bioceutical was acquired in 2018 for $835 millions. This acquisition gave our managers an opportunity to create a separate global brand which became MPXI International Corporation.

MPXI Corp. believes that building long-term international connections is the key to drive market shares. It is in our DNA to value sustainability, innovation and quality.

Founded MPX Bioceutical in

2015

Retail locations opened

12

Scaled our annual production to

8850kg

Revenue Run-Rate

$100milion+

Debt and Equity Financing

$105million+

Sold in 2018 for

$835million

Founded MPX Bioceutical in

2015

States expanded into

5

Retail locations opened

12

Premium SKUs

145+

Scaled our annual production to

8850kg

Debt and Equity Financing

$105million+

Melting Point Extracts (MPX) is our award-winning cannabis brand, devoted to providing the cleanest and most effective products possible. MPX specializes in Hydrocarbon, CO2, and solvent-free extractions to provide a diverse line of high-quality products including live resin concentrates, wax, sauce, and diamonds.

Meet

OUR TEAM

Holyworld SA

Alastair Crawford

Chief Executive

Louis-Philippe Escudié

Head of Business Development

Harnoor Grewall

Head of Business Strategy

Nicholas Varone

VP Extraction

Cédric Heeb

MPXI Labs

Board of Directors MPXI Corporation

Scott Boyes

Jeremy Budd

Alastair Crawford

Robert Petch

Randall Stafford

Management MPXI

Scott Boyes

CEO and Chairman

Jeremy Budd

Executive Vice President and General Counsel

Jonathan Chu

Vice President and CFO

Michael Arnkvahn

Chief Operating Officer

Karl Bartolo

General Manager – Malta

MPXI Board of Advisors

Dr. Charles Akle

Saul Greenblatt

Jean-Marc Levy

Discover

OUR ACTIVITIES

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.